Melichar B, Kohlova T, Vesely P. Survival after oxaliplatin therapy of irinotecan-pretreated advanced colorectal cancer patients.
Hepatogastroenterology. 2005 Nov-Dec;52(66):1707-14.  

Kabashima A, Sakaguchi Y, Okita K, Yamamura S, Ojima Y, Nishizaki T, Tashiro H, Matsuzaka T. [Efficacy of tegafur/uracil plus oral leucovorin therapy for advanced or recurrent colorectal cancer] Gan To Kagaku Ryoho. 2005 Nov;32(12):1935-8. Japanese.  

Sebag-Montefiore D, Glynne-Jones R, Falk S, Meadows HM, Maughan T. A phase I/II study of oxaliplatin when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group (CCOG) study. Br J Cancer. 2005 Oct 31;93(9):993-8.  

Alberts SR, Horvath WL, Sternfeld WC, Goldberg RM, Mahoney MR, Dakhil SR, Levitt R, Rowland K, Nair S, Sargent DJ, Donohue JH.Oxaliplatin, Fluorouracil, and Leucovorin for Patients With Unresectable Liver-Only Metastases From Colorectal Cancer: A North Central Cancer Treatment Group Phase II Study.J Clin Oncol. 2005 Oct 17; 

Nogue M, Salud A, Batiste-Alentorn E, Saigi E, Losa F, Cirera L, Mendez M, Campos JM, Galan A, Escudero P, Arcusa A, Manzano H, de Mendizabal EV, de Olaguer JP, Boleda M, Guasch I, Vicente P. Randomised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancer. Eur J Cancer. 2005 Oct;41(15):2241-9.  

Mukai M, Sato S, Ninomiya H, Wakui K, Komatsu N, Tsuchiya K, Nakasaki H, Makuuchi H. Recurrence and 5-FU sensitivity of stage II/Dukes' B colorectal cancer with occult neoplastic cells in lymph node sinuses. Oncol Rep. 2005 Nov;14(5):1171-6.  

Mukai M, Sato S, Ninomiya H, Wakui K, Komatsu N, Tsuchiya K, Nakasaki H, Makuuchi H. Recurrence and 5-FU sensitivity of stage III/Dukes' C colorectal cancer with occult neoplastic cells in lymph node sinuses. Oncol Rep. 2005 Nov;14(5):1165-9.  

Pachkoria K, Zhang H, Adell G, Jarlsfelt I, Sun XF. Significance of Cox-2 expression in rectal cancers with or without preoperative radiotherapy. Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):739-44.

Schuell B, Gruenberger T, Kornek GV, Dworan N, Depisch D, Lang F, Schneeweiss B, Scheithauer W. Side effects during chemotherapy predict tumour response in advanced colorectal cancer. Br J Cancer. 2005 Oct 3;93(7):744-8.  

Scappaticci FA, Fehrenbacher L, Cartwright T, Hainsworth JD, Heim W, Berlin J, Kabbinavar F, Novotny W, Sarkar S, Hurwitz H. Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab. J Surg Oncol. 2005 Sep 1;91(3):173-80.